The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
Distinguished Cardiologists and Scientists Honored with 2011 International Academy of Cardiology Awards
A world-renowned panel of 145 cardiologists and scientists, members of the Faculty of the International Academy of Cardiology (IAC) announced the 2011 International Academy of Cardiology Awards during the Opening Ceremony of the 16th World Congress on Heart Disease held in Vancouver, BC, Canada. Recipients include: Professor Maryl R. Johnson; Professor Dipak K. Das; Professor Nathan D. Wong; Professor Martin A. Alpert; and Professor Michael H. Criqui. Three faculty, Professor Lewis C. Becker, Professor Daniel S. Berman, and Professor Bodh I. Jugdutt were also honored with the Distinguished Fellowship Award. Asher Kimchi, M.D., Founder and Chairman of the IAC, said, "In the past 22 years the IAC has grown from a prestigious academy to one of the world's preeminent forums for top Cardiologists and Scientists. These Faculty are the best of the best. We are proud to honor them with these well-deserved awards." MORE»Dr. J.L. Mehta to deliver the fifth HJC Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, 16th World Congress on Heart Disease Annual Scientific Sessions 2011
Asher Kimchi, M.D., Founder and Chairman of the International Academy of Cardiology, today announced the selection of Jay Mehta, M.D., PhD., Director, Molecular Cardiology, Professor of Internal Medicine and Physiology and Biophysics and Stebbins Chair in Cardiology, University of Arkansas for Medical Sciences, Little Rock, to deliver the fifth H.J.C. Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, 16th World Congress on Heart Disease, Annual Scientific Sessions 2011 to be held in Vancouver, BC, Canada, from Saturday, July 23 through Tuesday, July 26, 2011.
Dr. Mehta will present on the topic of “Angiogenesis in Atherosclerosis; Mechanisms and Therapeutic Targets”. Angiogenesis or generation of new blood vessels has been known to be the basis of development of blood vessels in fetal life. Recently, angiogenesis has been shown to be a fundamental basis of growth and spread of certain tumors. Angiogenesis has also been identified in the media and adventitia of atherosclerotic blood vessels leading to the concept that atherosclerosis is “cancer of the blood vessels”. Work in his laboratory has suggested a potent role of reactive oxygen species released in response to the activation of angiotensin II and oxidized LDL receptor LOX-1 in angiogenesis. MORE»
California Teaching Hospitals That Used More Resources HadLower Mortality Rates “Looking Forward, Looking Back: Assessing Variations in Hospital Resource Use and Outcomes for Elderly Patients With Heart Failure," a study published in the early online edition of the journal Circulation: Cardiovascular Quality and Outcomes, concludes that California teaching hospitals with higher resource use in caring for hospitalized heart failure patients had lower mortality rates. Previous studies aimed at assessing how resources are used for expired elderly Medicare beneficiaries with heart failure, as a consequence of study design, have not been able to draw conclusions on health outcomes. Dr. Michael Ong et al’s study, "Looking Forward, Looking Back” departs from assessing expenditures on deceased patients exclusively in order to circumvent limitations of previous studies, namely: inability to identify differences in health outcomes across different hospitals and assuming patterns of resource use among all patients are well represented by resource use in expired patients. MORE» Effect of Intracoronary Streptokinase Administered Immediately After Primary Percutaneous Coronary Intervention on Long-Term Left Ventricular Infarct Size, Volumes, and Function A reduction in infarct size promises a substantial prognostic benefit after STEMI. Towards this aim, Murat Sezer, MD et al from Istanbul University in Capa-Istanbul, Turkey investigated if improvements in microvascular perfusion, measured by late phase infarct size and left ventricular volume and function, were obtainable with low dose adjuvant intracoronary streptokinase treatments given immediately after percutaneous coronary intervention. Their results, published in the September 15, 2009 issue of the Journal of the American College of Cardiology, showed that low-dose intracoronary streptokinase (ICSK) given immediately after primary percutaneous coronary intervention preserves left ventricular volumes and functions as well as significantly limits long-term infarct size. Their study concludes that low-dose ICSK administered immediately after primary PCI improves microvascular perfusion, decreases long-term infarct size, and improves LV volume and function.
MORE»
15th WORLD CONGRESS ON HEART DISEASE
Advances in Nuclear Cardiology and Cardiac CT: 27th Annual Case Review with the Experts
Valves in the Heart of the Big Apple VII: Evaluation & Management of Valvular Heart Disease 2012
CPP 2012 - The 2nd International Congress on Cardiac Problems in Pregnancy
Pan American Heart Failure Congress
Valves
in the Heart of the Big Apple VI: Evaluation &
Management of Valvular Heart Disease 2010
The First International Meeting on Cardiac Problems in Pregnancy
A world-renowned panel of 145 cardiologists and scientists, members of the Faculty of the International Academy of Cardiology (IAC) announced the 2011 International Academy of Cardiology Awards during the Opening Ceremony of the 16th World Congress on Heart Disease held in Vancouver, BC, Canada. Recipients include: Professor Maryl R. Johnson; Professor Dipak K. Das; Professor Nathan D. Wong; Professor Martin A. Alpert; and Professor Michael H. Criqui. Three faculty, Professor Lewis C. Becker, Professor Daniel S. Berman, and Professor Bodh I. Jugdutt were also honored with the Distinguished Fellowship Award. Asher Kimchi, M.D., Founder and Chairman of the IAC, said, "In the past 22 years the IAC has grown from a prestigious academy to one of the world's preeminent forums for top Cardiologists and Scientists. These Faculty are the best of the best. We are proud to honor them with these well-deserved awards." 
Asher Kimchi, M.D., Founder and Chairman of the International Academy of Cardiology, today announced the selection of Jay Mehta, M.D., PhD., Director, Molecular Cardiology, Professor of Internal Medicine and Physiology and Biophysics and Stebbins Chair in Cardiology, University of Arkansas for Medical Sciences, Little Rock, to deliver the fifth H.J.C. Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, 16th World Congress on Heart Disease, Annual Scientific Sessions 2011 to be held in Vancouver, BC, Canada, from Saturday, July 23 through Tuesday, July 26, 2011.
“Looking Forward, Looking Back: Assessing Variations in Hospital Resource Use and Outcomes for Elderly Patients With Heart Failure," a study published in the early online edition of the journal Circulation: Cardiovascular Quality and Outcomes, concludes that California teaching hospitals with higher resource use in caring for hospitalized heart failure patients had lower mortality rates. Previous studies aimed at assessing how resources are used for expired elderly Medicare beneficiaries with heart failure, as a consequence of study design, have not been able to draw conclusions on health outcomes. Dr. Michael Ong et al’s study, "Looking Forward, Looking Back” departs from assessing expenditures on deceased patients exclusively in order to circumvent limitations of previous studies, namely: inability to identify differences in health outcomes across different hospitals and assuming patterns of resource use among all patients are well represented by resource use in expired patients. 
A reduction in infarct size promises a substantial prognostic benefit after STEMI. Towards this aim, Murat Sezer, MD et al from Istanbul University in Capa-Istanbul, Turkey investigated if improvements in microvascular perfusion, measured by late phase infarct size and left ventricular volume and function, were obtainable with low dose adjuvant intracoronary streptokinase treatments given immediately after percutaneous coronary intervention. Their results, published in the September 15, 2009 issue of the Journal of the American College of Cardiology, showed that low-dose intracoronary streptokinase (ICSK) given immediately after primary percutaneous coronary intervention preserves left ventricular volumes and functions as well as significantly limits long-term infarct size. Their study concludes that low-dose ICSK administered immediately after primary PCI improves microvascular perfusion, decreases long-term infarct size, and improves LV volume and function.
